CRANBURY, N.J., Feb. 10, 2011 /PRNewswire/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Chairman and Chief Executive Officer John F. Crowley will be presenting a corporate overview at the upcoming 13th Annual BIO CEO and Investor Conference in New York, NY on Tuesday, February 15 at 2:00 p.m. EST.
A live webcast of the presentation will be available on the Investors section of the Amicus Therapeutics web site, http://www.amicustherapeutics.com. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will be available on the Company's web site for 30 days.
About Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company focused on developing treatments for rare diseases. The Company is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and CNS diseases. Amicus' lead program is in Phase 3 for the treatment of Fabry disease.
SOURCE Amicus Therapeutics